# International Money Express, Inc.: overview

IMXI · Nasdaq · CIK 1683695 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imxi.md) · [Financials](/companies/imxi/financials.md) · [Filings](/companies/imxi/filings.md) · [Insiders](/companies/imxi/insiders.md)

Latest reported revenue: [$131.2m](/filings/0001628280-26-055191.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001628280-26-055191).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [172](/filings/0001628280-25-051013.md) | [165 d](/filings/0001628280-26-015647.md) | [144](/filings/0001628280-26-033174.md) | [161](/filings/0001628280-26-055191.md) | [155](/filings/0001628280-25-051013.md) | [147 d](/filings/0001628280-26-015647.md) | [122](/filings/0001628280-26-033174.md) | [131](/filings/0001628280-26-055191.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [16.2%](/filings/0001628280-25-051013.md) | [15.0% d](/filings/0001628280-26-015647.md) | [9.8%](/filings/0001628280-26-033174.md) | [12.1%](/filings/0001628280-26-055191.md) | [6.8%](/filings/0001628280-25-051013.md) | [7.9% d](/filings/0001628280-26-015647.md) | [3.0%](/filings/0001628280-26-033174.md) | [6.7%](/filings/0001628280-26-055191.md) |
| Net margin | % | [10.1%](/filings/0001628280-25-051013.md) | [9.3% d](/filings/0001628280-26-015647.md) | [5.4%](/filings/0001628280-26-033174.md) | [6.8%](/filings/0001628280-26-055191.md) | [3.2%](/filings/0001628280-25-051013.md) | [6.1% d](/filings/0001628280-26-015647.md) | [0.4%](/filings/0001628280-26-033174.md) | [3.2%](/filings/0001628280-26-055191.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001628280-25-051013.md) | not reported | [0.25](/filings/0001628280-26-033174.md) | [0.37](/filings/0001628280-26-055191.md) | [0.17](/filings/0001628280-25-051013.md) | not reported | [0.02](/filings/0001628280-26-033174.md) | [0.14](/filings/0001628280-26-055191.md) |
| Free cash flow | $m | [23.4 d](/filings/0001628280-25-051013.md) | [(8.8) d](/filings/0001628280-26-015647.md) | [36.0](/filings/0001628280-26-033174.md) | [35.3 d](/filings/0001628280-26-055191.md) | [(35.5) d](/filings/0001628280-25-051013.md) | [(20.0) d](/filings/0001628280-26-015647.md) | [(42.9)](/filings/0001628280-26-033174.md) | [107 d](/filings/0001628280-26-055191.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [459](/filings/0001683695-24-000042.md) | [547](/filings/0001683695-25-000030.md) | [659](/filings/0001628280-26-015647.md) | [659](/filings/0001628280-26-015647.md) | [608](/filings/0001628280-26-015647.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [14.8%](/filings/0001683695-24-000042.md) | [15.2%](/filings/0001683695-25-000030.md) | [14.5%](/filings/0001628280-26-015647.md) | [14.4%](/filings/0001628280-26-015647.md) | [9.2%](/filings/0001628280-26-015647.md) |
| Net margin | % | [10.2%](/filings/0001683695-24-000042.md) | [10.5%](/filings/0001683695-25-000030.md) | [9.0%](/filings/0001628280-26-015647.md) | [8.9%](/filings/0001628280-26-015647.md) | [5.4%](/filings/0001628280-26-015647.md) |
| Diluted EPS | $ per share | [1.20](/filings/0001683695-24-000042.md) | [1.48](/filings/0001683695-25-000030.md) | [1.63](/filings/0001628280-26-015647.md) | [1.79](/filings/0001628280-26-015647.md) | [1.08](/filings/0001628280-26-015647.md) |
| Free cash flow | $m | [67.5](/filings/0001683695-24-000042.md) | [3.0](/filings/0001683695-25-000030.md) | [131](/filings/0001628280-26-015647.md) | [23.1](/filings/0001628280-26-015647.md) | [15.8](/filings/0001628280-26-015647.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/imxi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $33.3m | 2,305,506 |  | Added +240,754 |
| [Magnetar Financial LLC](/funds/1352851.md) | 2026-06-30 | $29.0m | 2,008,234 |  | Added +83,824 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $24.2m | 1,528,758 |  | Reduced −758,209 |
| [ODDO BHF ASSET MANAGEMENT SAS](/funds/1686970.md) | 2026-06-30 | $21.2m | 1,470,000 |  | New +1,470,000 |
| [Man Group plc](/funds/1637460.md) | 2026-06-30 | $18.1m | 1,252,360 |  | Reduced −51,809 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.8m | 1,231,381 |  | Added +9,505 |
| [FIL Ltd](/funds/318989.md) | 2026-06-30 | $17.4m | 1,203,780 |  | Reduced −1,689 |
| [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $16.6m | 1,149,315 |  | Added +620,602 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.5m | 1,072,979 |  | Added +930,474 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $14.4m | 998,949 |  | Added +145,551 |

## Recent filings

[All 682 filings](/companies/imxi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:18 ET | [8-K](/filings/0001140361-26-038416.md) | 8.01 Other events | 0001140361-26-038416 |
| 2026-08-10 | 20:02 ET | [10-Q](/filings/0001628280-26-055191.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055191 |
| 2026-05-11 | 13:30 ET | [10-Q](/filings/0001628280-26-033174.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033174 |
| 2026-04-30 | 20:24 ET | [10-K/A](/filings/0001628280-26-028928.md) | Annual report, amended, period 2025-12-31 | 0001628280-26-028928 |
| 2026-03-06 | 21:37 ET | [10-K](/filings/0001628280-26-015647.md) | Annual report, period 2025-12-31 | 0001628280-26-015647 |
| 2025-12-09 | 18:36 ET | [8-K](/filings/0001140361-25-044991.md) | 5.07 Shareholder vote results | 0001140361-25-044991 |
| 2025-11-10 | 21:06 ET | [10-Q](/filings/0001628280-25-051013.md) | Quarterly report, period 2025-09-30 | 0001628280-25-051013 |
| 2025-10-27 | 21:00 ET | [SCHEDULE 13D/A](/filings/0000921895-25-002808.md) | Ownership report, active investor, amended | 0000921895-25-002808 |
| 2025-10-07 | 20:36 ET | [8-K](/filings/0001140361-25-037505.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-037505 |
| 2025-09-11 | 16:18 ET | [SCHEDULE 13D/A](/filings/0001104659-25-089372.md) | Ownership report, active investor, amended | 0001104659-25-089372 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-015647.md), filed Mar 6, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cd937080-e34c-4800-beee-70206911896e)

## About the filer

- CIK: 1683695
- Tickers: IMXI
- Exchange: Nasdaq
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.